Last update March 29, 2023

C18H22I3N3O8

Compatible

Safe product and/or breastfeeding is the best option.

X-ray contrast medium with 48% iodine. It has been withhold from the market.

Metrizamide is excreted into breast milk in clinically non-significant amount, <0.1% of maternal dose. (Illet, 1981)

The various Iodinated contrast media for imaging examinations (X-rays, CT scans) are considered compatible with breastfeeding since they are rapidly eliminated with little or no release of iodine, not metabolized and virtually not absorbed when taken by mouth. They are structurally very similar to each other and one of them is their data no or minimal excretion in milk.

Given the low lipid solubility of the iodinated contrast, less than 1% of the dose administered to the mother just passing milk. Due to their low oral bioavailability, intestinal absorption is less than 1% of the dose that he may take the infant. The maximum dose just getting the baby is less than 0.01% of the maternal dose, which represents less than 1% of the dose administered to a nursing practice that is a radiological contrast examination.

Most experts and radiology scientific societies agree that after a radiological iodinated contrast examination is not necessary to wait no time to nurse.

American Academy of Pediatrics: medication usually compatible with breastfeeding.(AAP 2001)

Alternatives

We do not have alternatives for C18H22I3N3O8 since it is relatively safe.

Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it. The pharmaceutical industry contraindicates breastfeeding, mistakenly and without scientific reasons, in most of the drug data sheets.

Jose Maria Paricio, Founder & President of APILAM/e-Lactancia

Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.

Thank you for helping to protect and promote breastfeeding.

José María Paricio, founder of e-lactancia.

Other names

C18H22I3N3O8 is Metrizamide in Molecular formula.

Is written in other languages:

Group

C18H22I3N3O8 belongs to this group or family:

Tradenames

Main tradenames from several countries containing C18H22I3N3O8 in its composition:

Pharmacokinetics

Variable Value Unit
Oral Bioavail. 0.4 %
Molecular weight 789 daltons
pKa 11.75 -
Tmax 6 hours
24 hours
Relative Dose 0.02 %

References

  1. AAP - American Academy of Pediatrics Committee on Drugs. Transfer of drugs and other chemicals into human milk. Pediatrics. 2001 Sep;108(3):776-89. Abstract Full text (link to original source) Full text (in our servers)
  2. Ilett KF, Hackett LP, Paterson JW, McCormick CC. Excretion of metrizamide in milk. Br J Radiol. 1981 Abstract

Total visits

2,272

Help us improve this entry

How to cite this entry

Do you need more information or did not found what you were looking for?

   Write us at elactancia.org@gmail.com

e-lactancia is a resource recommended by Academy of Breastfeeding Medicine - 2015 of United States of America

Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM